PURPOSE: Herpetic stromal keratitis (HSK) is a T-cell-mediated
inflammatory disease initiated by a herpes simplex virus (HSV) infection
of the cornea. Recently, studies in the HSK mouse model have shown that
the immunopathogenic T cells are directed against the HSV protein UL6
cross-reacting with an unknown corneal autoantigen. Whether this type of
autoimmunity plays a role in human HSK was analyzed. METHODS: T-cell lines
(TCLs) were generated from corneal buttons of 12 patients with different
clinical stages of HSV-induced necrotizing stromal keratitis (n = 9) or
immune stromal keratitis (n = 3). The initiating virus was identified by
polymerase chain reaction and immunohistology performed on the corneal
buttons. Peripheral blood mononuclear cells (PBMCs) were isolated, and B
cell lines (BLCLs) were generated by transformation with Epstein-Barr
virus. Proliferative responses of these intracorneal TCLs were determined
by culturing T cells with autologous BLCLs infected with HSV-1, HSV-2,
wild-type vaccinia virus (VV-WT), or VV expressing HSV-1 UL6 (rVV-UL6).
Alternatively, T cells were incubated with PBMCs pulsed with human cornea
protein extract. RESULTS: Irrespective of clinical diagnosis or treatment,
T cells were recovered from the corneal buttons of all the 12 HSK
patients. The intracorneal TCLs of 9 of the 12 HSK patients showed
HSV-specific T-cell reactivity. In none of the TCLs, T-cell reactivity
against HSV-1 UL6 or human corneal antigens was detected. CONCLUSIONS:
These data suggest that the potentially immunopathogenic intracorneal
T-cell response in HSK patients is directed to the initiating virus and
not to a human corneal autoantigen or HSV-1 UL6